ImmunoPrecise Antibodies Cash from Financing (TTM) Insights

ImmunoPrecise Antibodies Ltd (IPA)

1.17 +0.04 (+3.70%) USD | NASDAQ | May 22, 16:00

1.185 +0.02 (+1.28%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1997. Upgrade now.

Date	Value
January 31, 2024	-0.3645M
October 31, 2023	-1.025M
July 31, 2023	-0.6522M
April 30, 2023	-0.467M
January 31, 2023	2.261M
October 31, 2022	2.431M
July 31, 2022	2.351M
April 30, 2022	2.298M
January 31, 2022	21.64M
October 31, 2021	22.06M
July 31, 2021	30.37M
April 30, 2021	33.15M
January 31, 2021	11.81M
October 31, 2020	11.40M
July 31, 2020	2.822M
April 30, 2020	0.1303M
January 31, 2020	-0.2688M
October 31, 2019	-0.4223M
July 31, 2019	6.347M
April 30, 2019	7.097M
January 31, 2019	10.49M
October 31, 2018	10.75M
July 31, 2018	8.294M
April 30, 2018	7.682M
January 31, 2018

Date	Value
October 31, 2017
July 31, 2017
April 30, 2017
January 31, 2017
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.025M

Minimum

Oct 2023

33.15M

Maximum

Apr 2021

7.676M

Average

2.351M

Median

Jul 2022

Cash from Financing (TTM) Benchmarks